A Phase 1, Fixed Sequence, Cross-Over Study To Estimate The Effect Of Multiple Dose Rifampin On The Single Dose Pharmacokinetics Of Crizotinib (PF-02341066) In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 May 2013
At a glance
- Drugs Crizotinib (Primary) ; Rifampicin
- Indications Cancer; Non-small cell lung cancer; Tuberculosis
- Focus Pharmacokinetics
- 15 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 15 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Sep 2010 New trial record